Futura Medical plc Financials

Market Capitalization £24.0 Million as of July 1, 2025

Valuations Metrics as of May. 5, 2024

Trailing PE	-1665.16
Forward PE	0.43
Price to Sales TTM	£35.77
Price to Book MRQ	£2044.44
Enterprise to Revenue	33.28
Enterprise to EBITDA	-15.10

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2023-12-31
Profit Margin	-210.03%
Operating Margin	-358.11%
Return on Assets TTM	-47.60%
Return on Equity TTM	-127.75%

Income Statement

Revenue TTM	£3,100,968
Revenue per Share TTM	£0.01
Quarterly Revenue Growth	%
Gross Profit TTM	£1,774,225
EBITDA	£-6,833,498
Net Income to Common TTM	£-6,512,899
Diluted EPS TTM	£-0.02
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	£7,714,182
Total Cash per Share MRQ	£0.03
Total Debt MRQ	£
Total Debt to Equity MRQ	0.00
Current Ratio MRQ	1.47
Book Value per Share MRQ	£0.02

Cash Flow

Operating Cash Flow TTM	£570,253
Levered Free Cash Flow TTM	£1,249,881

FUM Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding	301,448,992
Float Shares	254,947,237
Avg 10 Volume	381,470
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	33.75%
% Held by Institutions	37.10%

Stock Price Summary

Beta	1.24
Fifty Two Week Low	£23.28
Fifty Two Week High	£67.00
Fifty Two Week Change	-36.96%
Day 50 MA	£38.53
Day 200 MA	£38.40

Dividends and Splits

Forward Annual Dividend Rate	£
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	£0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date